Inventor
TYLER PETER CHARLES
NZ37 patents
⚠️ This page may combine multiple inventors who share the name “TYLER PETER CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EINSTEIN COLL MED
13 patentsUS5985848ANov 16, 1999
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED94 citations99
US6066722AMay 23, 2000
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED80 citations97
US7390890B2Jun 24, 2008
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED46 citations96
US7211677B2May 1, 2007
Process for preparing inhibitors of nucleoside metabolism
EINSTEIN COLL MED31 citations96
US6803455B2Oct 12, 2004
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED60 citations96
US6492347B2Dec 10, 2002
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED61 citations96
US6228847B1May 8, 2001
Inhibitors of nucleoside metabolism
EINSTEIN COLL MED62 citations96
US7109331B2Sep 19, 2006
5H-pyrrolo[3,2-d]pyrimidine nucleoside metabolism inhibitors
EINSTEIN COLL MED37 citations92
US7098334B2Aug 29, 2006
4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
EINSTEIN COLL MED40 citations92
US7022852B2Apr 4, 2006
Process for preparing inhibitors of nucleoside metabolism
EINSTEIN COLL MED31 citations92
US6764829B2Jul 20, 2004
Nucleoside hydrolase and nucleoside phosphorylase detection kits, dipsticks and substrates
EINSTEIN COLL MED30 citations92
US6379911B2Apr 30, 2002
Enzyme detection/assay method and substrates
EINSTEIN COLL MED28 citations92
US7777025B2Aug 17, 2010
Transition state analog inhibitors of ricin A-chain
EINSTEIN COLL MED11 citations84
VICTORIA LINK LTD
7 patentsUS9957272B2May 1, 2018
3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase
VICTORIA LINK LTD0 citations52
US10227351B2Mar 12, 2019
Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-D]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA)
VICTORIA LINK LTD0 citations51
US9994574B2Jun 12, 2018
Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-d]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA)
VICTORIA LINK LTD0 citations51
US11518779B2Dec 6, 2022
Inhibitors of DNMT1 as anticancer therapeutic agents
VICTORIA LINK LTD0 citations50
US11186603B2Nov 30, 2021
Heparan sulfate glycomimetic compounds and their pharmaceutical and cosmeceutical uses
VICTORIA LINK LTD0 citations42
US9828341B2Nov 28, 2017
Dendritic core compounds
VICTORIA LINK LTD0 citations39
US9879041B2Jan 30, 2018
Saccharide dendritic cluster compounds as inhibitors of BACE-1
VICTORIA LINK LTD0 citations36
IND RES LTD
6 patentsUS7211653B2May 1, 2007
Inhibitors of nucleoside metabolism
IND RES LTD33 citations96
US6693193B1Feb 17, 2004
Process for preparing 2-pyrrolidinyl-1H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism
IND RES LTD43 citations96
US7655795B2Feb 2, 2010
Process for preparing pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
IND RES LTD22 citations92
US7405297B2Jul 29, 2008
Process for preparing inhibitors of nucleoside metabolism
IND RES LTD24 citations92
US7553839B2Jun 30, 2009
5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
IND RES LTD31 citations91
US8383636B2Feb 26, 2013
Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase
IND RES LTD4 citations57
EVANS GARY BRIAN
3 patentsUS8283345B2Oct 9, 2012
Azetidine analogues of nucleosidase and phosphorylase inhibitors
EVANS GARY BRIAN7 citations82
US8173662B2May 8, 2012
Fused pyrimidines as inhibitors of nucleoside phosphorylases and nucleosidases
EVANS GARY BRIAN12 citations81
US9493465B2Nov 15, 2016
3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase
EVANS GARY BRIAN3 citations71